Cargando…
Time-Lag between Subretinal Fluid and Pigment Epithelial Detachment Reduction after Polypoidal Choroidal Vasculopathy Treatment
PURPOSE: The goal of the present research was to study post-treatment changes in polypoidal choroidal vasculopathy (PCV) shown by optical coherence tomography (OCT). METHODS: The study included 12 patients with naive PCV. Photodynamic therapy and 3 consecutive intravitreal bevacizumab injections at...
Autores principales: | Chae, Ju Byung, Lee, Joo Yong, Yang, Sung Jae, Kim, June-Gone, Yoon, Young Hee |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
The Korean Ophthalmological Society
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3060400/ https://www.ncbi.nlm.nih.gov/pubmed/21461221 http://dx.doi.org/10.3341/kjo.2011.25.2.98 |
Ejemplares similares
-
Polypoidal Choroidal Vasculopathy – A Type I Polypoidal Subretinal Neovasculopathy
por: Kokame, Gregg T
Publicado: (2013) -
Response to brolucizumab treatment for refractory serous pigment epithelial detachment secondary to polypoidal choroidal vasculopathy
por: Nam, Seung Wan, et al.
Publicado: (2022) -
Response of serous retinal pigment epithelial detachments to intravitreal aflibercept in polypoidal choroidal vasculopathy refractory to ranibizumab
por: Yamashita, Mariko, et al.
Publicado: (2014) -
The Therapeutic Effects of Bevacizumab in Patients with Polypoidal Choroidal Vasculopathy
por: Lee, Sun Young, et al.
Publicado: (2008) -
Rapid flattening of massive hemorrhagic retinal pigment epithelial detachment secondary to polypoidal choroidal vasculopathy after surgery
por: Zheng, Fang, et al.
Publicado: (2023)